Filing Flows › ELI Lilly (LLY) › Operating margin
ELI Lilly (LLY) operating margin by quarter
ELI Lilly's operating margin was 34.5% in Q3 2026 (third quarter 2026), -5.8 pts from Q2 2026. Over the last 7 quarters it ranged from 27.2% (Q1 2025) to 44.7% (Q1 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 34.5% | -5.8 pts | -6.6 pts |
| Q2 2026 | 40.2% | -4.4 pts | -3.3 pts |
| Q1 2026 | 44.7% | +1.9 pts | +17.5 pts |
| Q4 2025 | 42.8% | +1.8 pts | — |
| Q3 2025 | 41.1% | -2.5 pts | — |
| Q2 2025 | 43.6% | +16.4 pts | — |
| Q1 2025 | 27.2% | — | — |
Q3 2026 at a glance
ELI Lilly, Q3 2026: revenue $24.4B (+39% year over year), operating margin 34.5%, net earnings $6.5B, operating cash flow $11.4B. The chart follows the revenue to costs, profit and cash.
Questions
What is ELI Lilly's operating margin?
ELI Lilly's operating margin was 34.5% in Q3 2026 (third quarter 2026), -5.8 pts from Q2 2026.
How has ELI Lilly's operating margin changed?
Over the last 7 quarters it ranged from 27.2% (Q1 2025) to 44.7% (Q1 2026).